CD8a Antibody Super Bright 780 78-0081-82 from Thermo Fisher Scientific

Product Specs
ItemCD8a Antibody Super Bright 780
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog Number78-0081-82
Quantity100 µg
ApplicationsFlow Cytometry
Concentration0.2 mg/mL
Conjugate/TagSuper Bright™ 780
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
PurityAffinity chromatography
ReactivityMouse
TargetCD8a
IsotypeIgG2a kappa
Clone53-6.7
HostRat
NCBI Full Gene NameCD8 subunit beta 1, CD8 subunit alpha
NCBI Gene AliasesCd8b, Ly-35, Ly-B, Ly-C, Ly-2, Ly-3, Lyt-3, Lyt-2
ClonalityMonoclonal
Storage Temperature4° C, store in dark, DO NOT FREEZE!
Antibody TypePrimary
Storage4° C, store in dark, DO NOT FREEZE!

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivoCell Reports MedicineAugust 15, 2023Rohan Narayan, Mansi Sharma, Rajesh Yadav, Abhijith Biji, Oyahida Khatun, Sumandeep Kaur, Aditi Kanojia, Christy Margrat Joy, Raju Rajmani, Pallavi Raj Sharma, et al.for surface markers CD3 (Invitrogen, 47-0031-82), CD4 (Invitrogen, 11-0042-82), and CD8 (Invitrogen, 78-0081-82) as per manufacturer’s instructions. Data acquisition was performed on a Beckman Coulter CytoFLEX flow cytometer

(2) Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expressionScientific reportsJanuary 17, 2022Starikova AV, Skopenkova VV, Polikarpova AV, Reshetov DA, Vassilieva SG, Velyaev OA, Shmidt AA, Savchenko IM, Soldatov VO, Egorova TV, et al.

(3) Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a childNature medicineSeptember 1, 2021Ogishi M, Yang R, Aytekin C, Langlais D, Bourgey M, Khan T, Ali FA, Rahman M, Delmonte OM, Chrabieh M, et al.7 (Invitrogen, Cat: 25–0041-82, Clone: GK1.5, 1:500), anti-CD8-Super Bright 780 (eBioscience, Cat: 78–0081-82, Clone: 53–6.7, 1:500) antibodies for 20 minutes at 4°C. The cells were fixed with the True-Nuclear

(4) Chronic T cell proliferation in brains after stroke could interfere with the efficacy of immunotherapiesThe Journal of experimental medicineAugust 2, 2021Heindl S, Ricci A, Carofiglio O, Zhou Q, Arzberger T, Lenart N, Franzmeier N, Hortobagyi T, Nelson PT, Stowe AM, et al.

(5) Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interactioneLifeJune 14, 2021Ramos MIP, Tian L, de Ruiter EJ, Song C, Paucarmayta A, Singh A, Elshof E, Vijver SV, Shaik J, Bosiacki J, et al.

(6) Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination ModelVaccinesMay 10, 2021Vernet R, Charrier E, Cosset E, Fièvre S, Tomasello U, Grogg J, Mach N.Thermo Fisher Scientific, 64-0042-82), SB780-conjugated anti-mouse CD8a (clone: 53-6.7, Thermo Fisher Scientific, 78-0081-82), PE-CF594-conjugated anti-mouse Ly6g/Ly6c (clone: RB6-8C5, BD Bioscience, 562710), PE-CF594-conjugated

(7) A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory CellsFrontiers in immunologyJanuary 1, 2021Di Giorgio E, Wang L, Xiong Y, Christensen LM, Akimova T, Han R, Samanta A, Trevisanut M, Brancolini C, Beier UH, et al.

(8) Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapyJournal for immunotherapy of cancerNovember 1, 2020Gao H, Wu Y, Shi J, Zhang X, Liu T, Hu B, Jia B, Wan Y, Liu Z, Wang F.

(9) Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophagesEMBO molecular medicineOctober 7, 2020Menga A, Serra M, Todisco S, Riera-Domingo C, Ammarah U, Ehling M, Palmieri EM, Di Noia MA, Gissi R, Favia M, et al.

(10) The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cellsNature communicationsSeptember 17, 2020Naka K, Ochiai R, Matsubara E, Kondo C, Yang KM, Hoshii T, Araki M, Araki K, Sotomaru Y, Sasaki K, et al.

(11) TIAM2S Mediates Serotonin Homeostasis and Provokes a Pro-Inflammatory Immune Microenvironment Permissive for Colorectal TumorigenesisCancersJuly 8, 2020Chan YL, Lai WC, Chen JS, Tseng JT, Chuang PC, Jou J, Lee CT, Sun HS.

(12) Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammationThe Journal of experimental medicineJuly 6, 2020Devos M, Tanghe G, Gilbert B, Dierick E, Verheirstraeten M, Nemegeer J, de Reuver R, Lefebvre S, De Munck J, Rehwinkel J, et al.

(13) A Cu₉S₅ nanoparticle-based CpG delivery system for synergistic photothermal-, photodynamic- and immunotherapyCommunications biologyJuly 3, 2020Zhou L, Chen L, Hu X, Lu Y, Liu W, Sun Y, Yao T, Dong C, Shi S.

(14) Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammationScience advancesMay 1, 2020Ma C, Yang D, Wang B, Wu C, Wu Y, Li S, Liu X, Lassen K, Dai L, Yang S.

(15) Artificial Mini Dendritic Cells Boost T Cell-Based Immunotherapy for Ovarian CancerAdvanced science (Weinheim, Baden-Wurttemberg, Germany)April 1, 2020Cheng S, Xu C, Jin Y, Li Y, Zhong C, Ma J, Yang J, Zhang N, Li Y, Wang C, et al.

(16) Loss of testosterone impairs anti-tumor neutrophil functionNature communicationsMarch 31, 2020Markman JL, Porritt RA, Wakita D, Lane ME, Martinon D, Noval Rivas M, Luu M, Posadas EM, Crother TR, Arditi M.

(17) Specific targeting of IL-1β activity to CD8⁺ T cells allows for safe use as a vaccine adjuvantNPJ vaccinesJanuary 1, 2020Van Den Eeckhout B, Van Hoecke L, Burg E, Van Lint S, Peelman F, Kley N, Uzé G, Saelens X, Tavernier J, Gerlo S.

(18) RIPK3 and Caspase-1/11 Are Necessary for Optimal Antigen-Specific CD8 T Cell Response Elicited by Genetically Modified Listeria monocytogenesFrontiers in immunologyJanuary 1, 2020Rana A, de Almeida FC, Paico Montero HA, Gonzales Carazas MM, Bortoluci KR, Sad S, Amarante-Mendes GP.

(19) HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune MicroenvironmentJournal of CancerJanuary 1, 2020Kim YD, Park SM, Ha HC, Lee AR, Won H, Cha H, Cho S, Cho JM.

(20) ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical modelsPloS oneJanuary 1, 2020Hanson A, Elpek K, Duong E, Shallberg L, Fan M, Johnson C, Wallace M, Mabry GR, Sazinsky S, Pepper L, et al.

Write a Review

(1)

3/18/2021Stains CD8+ Cells Very Well Robert YuanWe wanted to examine T cells in the healthy vs diseased state, so we used this antibody to identify T cells in the spleen.

Flow

Flow

CD8a Antibody Super Bright 780 from Thermo Fisher Scientific

Thermo Fisher Scientific

Citations (21)

Reviews

CD8a Antibody Super Bright 780 from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map